Phase 4 Hepatocellular Clinical Trials
8 recruitingPhase 4
What is a Phase 4 trial?
Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.
Showing 1–8 of 8 trials
Recruiting
Phase 4
Atezolizumab and Bevacizumab in Combination With Y^90 Radioembolization in HCC for Liver Transplant
Hepatocellular Carcinoma
Icahn School of Medicine at Mount Sinai40 enrolled1 locationNCT07059494
Recruiting
Phase 4
National Liver Cancer Screening Trial
Liver CancerCarcinoma, HepatocellularLiver Cirrhosis+1 more
University of Texas Southwestern Medical Center5,500 enrolled18 locationsNCT06084234
Recruiting
Phase 4
The Treatment of Liver Injury After Liver Resection With Polyene Phosphatidylcholine
Hepatocellular Carcinoma (HCC)Liver Diseases
Anhui Provincial Hospital96 enrolled1 locationNCT07150624
Recruiting
Phase 4
Efficacy & Safety of Anticoagulants in Cirrhosis ± HCC
CirrhosisHCC - Hepatocellular CarcinomaPortal Vein Thrombosis
Mansoura University100 enrolled1 locationNCT07132515
Recruiting
Phase 4
Endoscopic Variceal Ligation vs Carvedilol for the Prevention of First Esophageal Variceal Bleeding in Patients With HCC
Hepatocellular Carcinoma (HCC)Esophageal Varices
Taipei Veterans General Hospital, Taiwan120 enrolled1 locationNCT06594744
Recruiting
Phase 4
Atezolizumab and Bevacizumab Pre-Liver Transplantation for Patients With Hepatocellular Carcinoma Beyond Milan Criteria
Hepatocellular CarcinomaHepatocellular Cancer
The Methodist Hospital Research Institute24 enrolled1 locationNCT05185505
Recruiting
Phase 4
Impact of Propofol-Based Total Intravenous Anesthesia Versus Anesthesia With Sevoflurane on Long-term Outcomes With Patients Undergoing Elective Excision of Primary Liver Tumors
Hepatocellular Carcinoma
Kaohsiung Medical University Chung-Ho Memorial Hospital500 enrolled1 locationNCT05331911
Active
Phase 4
A randomized clinical trial of adefovir to treat patients with hepatitis B-related hepatocellular carcinoma after radical tumor resection
whether adefovir can prolong the disease-free survival and overall survival of hepatocellular carcinoma patients with HBV-DNA >=10000 copies/ml
Eastern hepatobiliary hospital200 enrolled1 locationACTRN12611000840987